StudyFormycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206 10.07.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

Novo Nordisk invests €2.34B to expand its Anagni facility near Rome, enhancing production of diabetes and obesity treatments ...

Merck (MSD outside US & Canada) announces $10B acquisition of Verona Pharma to enhance its respiratory portfolio with COPD ...

The global Esoteric Testing Market is valued at USD 30.56 billion in 2024 and is projected to reach a value of USD 84.12 ...

Actithera, a radiopharmaceutical biotech pioneering precision radioligand therapies, has closed an oversubscribed Series A ...

Innovation in pharmaceutical secondary packaging is so much more than a competitive advantage – in today’s market, it is a ...

Half Year ReportHeidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business 10.07.2025 / 07:03 CET/CESTThe issuer is solely responsible for the content of this ...

First comprehensive sell-side report on TRNR cites more than 800% growth in expected 2025 revenueValuation driven by stock-for-stock M&A model and potential crypto-treasury upside AUSTIN, TEXAS / ...

UniDoc showcases its ongoing humanitarian and healthcare innovation efforts at international event in Rome, Italy VANCOUVER, BC / ACCESS Newswire / July 9, 2025 / UniDoc Health Corp.

Monroe County Hospital increases swing bed program census by 21% in less than 12 months, then up to 40% after 18 months. WATKINSVILLE, GA / ACCESS Newswire / July 9, 2025 / Inpatient beds that can ...

UPPSALA, SWEDEN / ACCESS Newswire / July 9, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) today announced that its licensee, Fukuda Denshi, has received FDA and UKCA approvals to launch its integrated HN-100 ...

Transplants can be life-saving – but for many, the journey doesn’t end there. Up to 40% of people receiving a stem cell or bone marrow transplant will go on to develop a serious complication known as ...